Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Alkermes initiates phase III Vivitrol study for opioid dependence

June 27, 2008

US WorldMeds reports initial results from phase III clinical trial of lofexidine

June 19, 2008

Novartis launches oral iron-chelating agent Exjade for chronic iron overload in Japan

June 16, 2008

Targacept designates neuronal nicotinic receptor drug in smoking cessation program

May 7, 2008

DOR BioPharma initiates nonhuman primate efficacy studies of RiVax ricin toxin vaccine

May 2, 2008

Independent Pharmaceutica initiates phase II clinical trial of Niccine for nicotine dependence

April 30, 2008

Champix set for Japanese launch

April 22, 2008

Novartis receives approval for Exjade in Japan

April 18, 2008

Modafinil improves cocaine abstinence in some addicted patients

April 9, 2008

Department of Defense awards contract to Cleveland BioLabs to develop Protectan

April 8, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...